Aperio Group’s LivePerson LPSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$2.81M Sell
3,016
-23
-0.8% -$19.8K 0.01% 1075
2020
Q3
$2.37M Buy
3,039
+233
+8% +$175K 0.01% 1037
2020
Q2
$1.74M Buy
2,806
+107
+4% +$49.8K 0.01% 1166
2020
Q1
$921K Sell
2,699
-383
-12% -$186K ﹤0.01% 1344
2019
Q4
$1.71M Sell
3,082
-85
-3% -$48.8K 0.01% 1166
2019
Q3
$1.7M Buy
3,167
+156
+5% +$82.8K 0.01% 1127
2019
Q2
$1.27M Sell
3,011
-23
-0.8% -$9.81K 0.01% 1268
2019
Q1
$1.32M Hold
3,034
0.01% 1225
2018
Q4
$858K Sell
3,034
-149
-5% -$45.9K ﹤0.01% 1395
2018
Q3
$1.24M Sell
3,183
-269
-8% -$99.2K 0.01% 1283
2018
Q2
$1.09M Sell
3,452
-1,812
-34% -$512K 0.01% 1329
2018
Q1
$1.29M Buy
5,264
+500
+10% +$100K 0.01% 1182
2017
Q4
$822K Sell
4,764
-24
-0.5% -$4.49K ﹤0.01% 1426
2017
Q3
$973K Buy
4,788
+155
+3% +$29.8K 0.01% 1282
2017
Q2
$765K Buy
4,633
+220
+5% +$30.2K ﹤0.01% 1390
2017
Q1
$453K Buy
4,413
+929
+27% +$99.3K ﹤0.01% 1604
2016
Q4
$395K Buy
3,484
+232
+7% +$28.7K ﹤0.01% 1653
2016
Q3
$410K Buy
3,252
+751
+30% +$85.6K ﹤0.01% 1568
2016
Q2
$238K Buy
+2,501
New +$239K ﹤0.01% 1772

Other funds holding LPSN

Aperio Group's LPSN Position: Q4 2020 in Review

Aperio Group reduced its LivePerson (LPSN) stake by 0.76% in Q4 2020, selling an estimated $19.8K and leaving 3,016 shares worth $2.81M. The position accounts for 0.01% of the portfolio, ranked #1075.

Aperio Group first reported a position in LPSN in Q2 2016 and has held it in 19 quarters since. 279 funds tracked by Wall St. Rank hold LPSN as of Q4 2020.

  • Aperio Group held 3,016 shares of LivePerson worth $2.81M as of Q4 2020.
  • Aperio Group sold 23 LivePerson shares in Q4 2020, an estimated $19.8K.
  • LivePerson made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1075 holding.
  • Aperio Group first reported a position in LivePerson in Q2 2016 and has held it in 19 quarters since.
  • 279 funds tracked by Wall St. Rank held LivePerson as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.